Post mortem sampling of the brain and other tissues in neurodegenerative disease
暂无分享,去创建一个
[1] D. Dickson,et al. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.
[2] D. Bennett,et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.
[3] A. Gray,et al. Estimating the relationship between disease progression and cost of care in dementia , 2002, British Journal of Psychiatry.
[4] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[5] Yoav Ben-Shlomo,et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.
[6] M Knapp,et al. Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding , 2001, International journal of geriatric psychiatry.
[7] K. Fischbeck. Polyglutamine expansion neurodegenerative disease , 2001, Brain Research Bulletin.
[8] Andrew J. Lees,et al. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.
[9] Michel Goedert,et al. Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.
[10] R A Crowther,et al. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[11] N P Quinn,et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[12] J. Growdon,et al. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.
[13] I Litvan,et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias , 1999, Neurology.
[14] Linda Teri,et al. Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.
[15] P. Hobson,et al. Accuracy of diagnosis in patients with presumed Parkinson's disease. , 1999, Age and ageing.
[16] J. Hardy,et al. Genetic classification of primary neurodegenerative disease. , 1998, Science.
[17] James Lowe,et al. Establishing a Pathological Diagnosis in Degenerative Dementias , 1998, Brain pathology.
[18] J. Trojanowski,et al. Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.
[19] J. Ironside. Oppenheimer's Diagnostic Neuropathology: A Practical Manual , 1997 .
[20] J. Bell,et al. The ‘high‐risk’ neuropathological autopsy in AIDS and Creutzfeldt‐Jakob disease: principles and practice , 1996, Neuropathology and applied neurobiology.
[21] D. Perl. Oppenheimer's Diagnostic Neuropathology: A Practical Manual , 1996 .
[22] W. Schlote,et al. [Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action]. , 1996, Der Pathologe.
[23] I Litvan,et al. Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.
[24] W. Schlote,et al. Tissue Handling in Suspected Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) , 1995, Brain pathology.
[25] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[26] S. Love,et al. Demonstration of mitochondrial ribosomal RNA in frozen and paraffin–embedded sections of skeletal muscle by in situ hybridization , 1994, Neuropathology and applied neurobiology.
[27] A. Lees,et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.
[28] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[29] S. Love,et al. Qualitative and quantitative morphology of human sural nerve at different ages. , 1985, Brain : a journal of neurology.
[30] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[31] R. Beesley,et al. A Simple Method for Preparing Serial Blocks of Tissue , 1956, Journal of clinical pathology.
[32] G. Tremblay. Neuropathology , 1935, Neurology.
[33] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[34] R. Weller,et al. Autopsy investigation of disorders of skeletal muscle and peripheral nerves. , 2001, Current topics in pathology. Ergebnisse der Pathologie.
[35] J. Lowe. The pathological diagnosis of neurodegenerative diseases causing dementia. , 2001, Current topics in pathology. Ergebnisse der Pathologie.
[36] J. Ironside,et al. Investigation of prion diseases. , 2001, Current topics in pathology. Ergebnisse der Pathologie.
[37] Mrc Psych,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .